Discovery and Research

Discovery from public oncological data using QIAGEN Omicsoft OncoLand and QIAGEN Ingenuity Pathway Analysis - June 17 2021

June 24, 2021
In this 90-minute training, we will discuss how to discover and validate biomarkers as well as drug targets and key genes using public oncological data from GEO, TCGA, CCLE and other sources. To do this, we will use QIAGEN Omicsoft OncoLand, QIAGEN Ingenuity Pathway Analysis (IPA) and the OmicSoft Land Explorer web interface.

Specifically, for conditions of interest (diseases, cell lines, treatments etc.), we will discuss how to:
• Identify public studies of interest
• Derive a biomarker/gene signature
• Study expression of a gene or drug target
• Correlate expression of multiple genes and biomarkers
• Visualize a gene signature in the context of a heatmap
• Compare public data with other public data or a user’s own data

Speaker: Sumana Chintalapudi, Ph.D., Field Application Scientist, QIAGEN Digital Insights

Related videos

Discovery and Research

Discover hidden relationships in your toxicological studies with QIAGEN IPA

263 views May 18, 2020

QIAGEN Ingenuity Pathway Analysis (IPA) reveals the hidden upstream drivers...

Discovery and Research

Multi-omic changes in the postnatal mouse heart identified by QIAGEN Ingenuity Pathway Analysis...

264 views May 18, 2020

Multi-omics experiments allow researchers to make important discoveries in...

Discovery and Research

Using QIAGEN Digital Insights to determine how LY6E impairs coronavirus fusion and confers immune...

313 views May 08, 2020

Zoonotic coronaviruses (CoVs) are significant threats to global health, as...

Discovery and Research

From data to biological insight using QIAGEN CLC Single Cell Module and QIAGEN IPA: Single-cell...

91 views June 11, 2021

Organ development during gestation is a complex series of hematopoietic...